Tonelli F, Dolara P, Batignani G, Monaci I, Caderni G, Spagnesi M T, Luceri C, Amorosi A
Department of Clinical Physiopathology, University of Florence, Italy.
Dis Colon Rectum. 1995 Sep;38(9):974-8. doi: 10.1007/BF02049735.
To verify whether short chain fatty acids (SCFA) alter the proliferative and endoscopic pattern of the mucosa in ileal pouches of ulcerative colitis (UC) or familial adenomatous polyposis (FAP) patients.
We studied patients after proctocolectomy carrying a pelvic ileal pouch for FAP or UC (noncanalized pouches in 10 UC and 4 FAP patients and canalized pouches in 6 UC and 5 FAP patients). Patients with noncanalized pouches were treated twice daily for one week with 30 ml of a SCFA solution (60 mM sodium acetate, 30 mM sodium propionate, 40 mM sodium butyrate, and 22 mM sodium chloride, pH 7); patients with canalized pouches were treated with the same solution twice daily for two weeks. Pouch mucosal biopsies were collected before and after SCFA. Mucosal proliferation was assessed by incorporation of [3H]thymidine in vitro and autoradiography.
In UC patients proliferation did not vary in noncanalized pouches but was significantly reduced in canalized pouches after SCFA. In FAP patients SCFA did not alter proliferation. No significant effects of SCFA were observed on daily defecation frequency, endoscopic appearance, or histopathology of the pouches.
SCFA do not control inflammation and clinical functions but reduce cell proliferation in UC patients. On the contrary, FAP patients are refractory to SCFA.
验证短链脂肪酸(SCFA)是否会改变溃疡性结肠炎(UC)或家族性腺瘤性息肉病(FAP)患者回肠袋黏膜的增殖和内镜表现模式。
我们研究了接受直肠结肠切除术后带有盆腔回肠袋的FAP或UC患者(10例UC患者和4例FAP患者的非造口袋,以及6例UC患者和5例FAP患者的造口袋)。非造口袋患者每天用30毫升SCFA溶液(60 mM醋酸钠、30 mM丙酸钠、40 mM丁酸钠和22 mM氯化钠,pH 7)治疗两次,持续一周;造口袋患者用相同溶液每天治疗两次,持续两周。在SCFA治疗前后采集袋黏膜活检样本。通过体外掺入[3H]胸腺嘧啶核苷和放射自显影评估黏膜增殖。
在UC患者中,非造口袋的增殖没有变化,但SCFA治疗后造口袋的增殖显著降低。在FAP患者中,SCFA没有改变增殖情况。未观察到SCFA对袋的每日排便频率、内镜表现或组织病理学有显著影响。
SCFA不能控制炎症和临床功能,但可降低UC患者的细胞增殖。相反,FAP患者对SCFA不敏感。